Why the study?
Does telmisartan or combined telmisartan and ramipril reduce cardiovascular events compared to ramipril alone?
Does telmisartan or combined telmisartan and ramipril reduce cardiovascular events compared to ramipril alone?
Answers are grounded in this paper and cite their sources.
Combined therapy with ramipril and telmisartan does not improve cardiovascular outcomes compared to monotherapy but increases the risk of symptomatic hypotension and acute dialysis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nasrulla Abutaleb (2009) reported an editorial. Telmisartan or combined telmisartan and ramipril vs. Ramipril was evaluated on Cardiovascular (CV) death, myocardial infarction (MI), stroke or hospitalization for heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: